Form D · Biotechnology
Biolinq Inc
San Diego, CA · CIK 0001685406
Offering snapshot reported Mar 21, 2025 · SEC filing
- Reported sold
- $90M Offering amount: $100M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2025 | Initial | $90,000,000 | No comparison | 45 | SEC filing |
| Sep 13, 2024 | Amendment | $59,139,615 | $5,390,000vs Mar 26, 2024 | 43 | SEC filing |
| Mar 26, 2024 | Amendment | $53,749,615 | $18,635,000vs Dec 26, 2023 | 42 | SEC filing |
| Dec 26, 2023 | Initial | $35,114,615 | No comparison | 25 | SEC filing |
| Jun 1, 2022 | Amendment | $77,946,902 | $15,768,471vs Sep 17, 2021 | 62 | SEC filing |
| Sep 17, 2021 | Initial | $62,178,431 | No comparison | Not reported | SEC filing |
| Mar 23, 2021 | Initial | $5,223,811 | No comparison | 21 | SEC filing |
| Jul 7, 2020 | Amendment | $3,554,335 | $0vs Apr 7, 2020 | 17 | SEC filing |
| Apr 7, 2020 | Initial | $3,554,335 | No comparison | 17 | SEC filing |
| Mar 20, 2019 | Initial | $3,000,000 | No comparison | 9 | SEC filing |
| Nov 27, 2017 | Initial | $8,115,919 | No comparison | 17 | SEC filing |
| Sep 28, 2016 | Initial | $450,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541825
Source: Form D, filed Mar 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Arida | Executive |
| David Berry | Director |
| Zina Affas Besse | Director |
| Dan Bradbury | Director |
| Daniel Bradbury | Director |
| Chris Dimitropoulos | Director |
| Lana Ghanem | Director |
| Nancy Hong | Director |
| Thad Johnson | Director |
| Edward Kliphuis | Director |
| Derek Rapp | Director |
| Jared Affas Tangney | Executive |
| Joshua Windmiller | Executive |
| Richard Yang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10260 Sorrento Valley Road
San Diego, CA, 92121
San Diego, CA, 92121